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Abstract  
Autism is a neurological disorder of childhood with poorly understood, in terms of its etiology and pathology. 
Oxidative stress may play a role in the disease pathophysiology. Oxidative stress results in an excess of free 
radicals which leading to organ dysfunction. Mitochondria are the main intracellular source of free radicals. In 
this experimental study, an innovative approach of using a DC electrical pulsating device with an antioxidants 
supplements in early treatments of disease is introduced. The current study included (20) autistic children as the 
intervention group and (20) non-autistic children as a control. The intervention group received an 
electromagnetic treatments and the antioxidants supplements for four months. Their autistic states were 
evaluated according to the Autism Treatment Evaluation Checklist (ATEC). Lactate (The mitochondrial 
dysfunction biomarker), Ceruloplasmin and Transferrin were tested for the presence of the oxidative stress. Pre-
treatment values were compared with post- treatment values and with standard values. Results indicate that there 
is a significant decrease in lactate values after intervention (mean ± SD 2.6 ± 0.82 and 1.88 ± 0.61) pre- and post 
intervention. Assessment of the autism state by (ATEC) reported that 90% of the respondents showed a decrease 
in total ATEC scores after the treatment process by an average of 69.28%. The strong correlation of the 
oxidative stress biomarkers  associated with autism severity. Suggesting a good ground to use electromagnetic 
and antioxidant supplements treatment for autistic children.  
Keywords: electromagnetic therapy, autism, oxidative stress, mitochondrial dysfunction, food supplements. 
 
1. Introduction 
It is well known that electrical fields is generated by cells and tissues activity. Each cell in body is positively and 
negatively charged and needs to be kept balanced .i.e., polarized. The biomagnetic fields throughout the body 
maintain this balance in the cells. Different studies stated that an imbalance of the electromagnetic frequencies of 
energy can cause illness. 
The depolarization of cells is due to the accumulation of the free radicals, since they are atoms, 
molecules or ions with positive and negative charges surrounded the cell membrane. Free radicals are produced 
from either endogenous sources (Halliwell et. al., 1995), or from exogenous sources (Lobo,et.al.,2010). 
Mitochondria are the primary source of reactive oxygen species (ROS) by electron leak from the electron 
transport chain. 
Different studies suggested that the Electromagnetic therapy is effective on any living cell to restore its 
polarization, by reducing its free radicals content. 
An Asian study reported that electromagnetic pulse prevents free radical generation by activating 
antioxidant enzyme activity and reducing oxygen consumption. Wang, et.al., ( 2013). 
In addition to that another study reported that the electromagnetic pulses accelerate healing by acting as 
a catalyst for the antioxidants to connect with the free radicals which are the primary culprit in diseases. Glen 
Gordan (2007) 
Moreover, a study proposed that Pulses Electromagnetic Frequencies (PEMF) devices offer abundant 
free electrons to the human body, in addition to plentiful negative ions. Such a flood of free electrons, 
penetrating through permeable membrane throughout the tissues, and affect the ATP production in the Krebs 
cycle. Thomas F. Valone (2003) 
Two earlier research studies showed that there is a statistical correlation between the electro-stimulation 
of key acupuncture points with a reduction in free radicals and an improved emotional state. Russell (2005) and 
Shealy (2002) 
Autism is a prevalent neuro-developmental disorder disease, the disorder has an association with 
language severe impairment, in addition to cognition as well as socialization (Lord et.al., 2000 ; Austin, 2008) 
Many studies reported the role of the oxidative stress in the pathophysiology of autism disease. 
( McGinnis,R. 2004; Maria E. et.al., 2013; El-Ansary A. et.al., 2010). Oxidative stress results in a surplus of free 
radicals, which can lead to a react with cellular lipids, proteins, and nucleic acids ending in injury and final organ 
dysfunction. (Jacobson MD,1996 ). 
A strong connection between mitochondrial diseases and autism and oxidative stress has been found, 
possibly due to an intervention between genetics and the environment. Mitochondria are primary source of ROS 
electron leak from the electron transport chain. A recent study (2010) at University of California Davis showed 
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that 80% of children with ASD enrolled in their study had blood tests indicating mitochondrial dysfunction 
(Giulivi, et.al.,2010). Another study reviewed eighteen publications representing a total of 112 children with 
ASD and MD (ASD/MD) were identified. They found that the prevalence of development regression (52%), 
seizures (41%), motor delay (51%), gastrointestinal abnormalities (78%), and pyruvate (45%) was significantly 
higher in ASD/MD compared with the general ASD population ( Rossignol, DA, and Frye RE, 2012). A lactate 
level is a simple, non-evasive , low-cost means for the initial diagnostic approach of mitochondrial dysfunction. 
(Zeviani 1996). 
Both Ceruloplasmin as well transferrin are major antioxidant proteins. In addition Ceruloplasmin works as 
ferroxidase, it also protects polyunsaturated fatty acids from active oxygen radicals in red blood cell 
membranes.( Arnaud et al.,1988). Transferrin works as an antioxidant by reducing the concentration of free 
ferrous ion ( Loeffler et al., 1995). 
Objectives of this experimental study, were to introduce an innovative approach of using a simple DC 
electrical pulsating device with an antioxidants supplements in early treatments of autism. 
 
2. Materials and Methods 
2.1. Ethical statement 
Participation jn the study was voluntary and anonymous. A written consent was obtained from the parents of 
each individual case. During the experiment time, each participants assigned with a code number in conjunction 
with initial selection. These numbers were in lieu of their names for all data records. The study followed 
principles in the Declaration of Helsinki. 
 
2.2. Description of the device: 
The device was invented by the first author ( H. Abu Elasal). The device consists of three parts; the first is a 
timing circuit with a 9 volt supply voltage which produce a number of pulses per seconds according to the nature 
of the disease, the second is a switching circuit and the third is a two copper electrodes ( positive and negative) 
the first was connected with a specific point on the human body and with the other was connected to the right or 
the left hand. 
This research inspects the effectiveness of electro-stimulation on specific skin points, in the attempt to 
reduce the free radical activity and increase the antioxidants capacity, as well as to determine the outcome of the 
intervention on the autistic state of the participants. 
 
2.3. Sampling and Setting: 
Participants were selected from autism-specific schools in Irbid- Jordan. All children met criteria for diagnosis of 
autism on (SCARS) scores (Scopler, et.al., 1980), while the diagnosis was established in a previous assessment 
by either a child psychiatrist or psychologist. 
Twenty children diagnosed with autism were selected (14 males and 6 females) the age ranged between 
3 to 15 years. All children were in good physical health. 
A local clinic was used to control the experiment, so that the area can supervised, it was conducted at 
the My Health Medical Center (Irbid –Jordan), and the biochemical tests were carried out at Biolab and Al-Amal 
Specialized Lab. (Irbid –Jordan). 
 
2.4. Experimental Design: 
The study was conducted over a period of four months. A pre-post testing was conducted for each participants. 
Pre-test: During the first day of the study, all participants children were surveyed and examined for the 
following :1- using (ATEC) scores to measure their autistic state; 2- the lactate test to assess the mitochondrial 
dysfunction; and 3- ceruloplasmin and transferrin test to evaluate the antioxidant capacity of the participants. 
Over a period of four months the intervention group received the electro- stimulation treatments on 
specific skin points, each participants received one to two session per week, each session lasted for 15 to 20 
minutes. At the same time the intervention group supplied with vitamin C, vitamin E and Selenium ( 50 mg, 10 
IU, and 20 mcg) respectively. Since, The Recommended Dietary Allowances (RDA) for children (1-10 years) 
were (40-50 mg, 10.5 IU and 30 mcg) respectively. Food and Nutrition Board (FNB) ( 1989). 
Post-test: At the end of the interventions, all of the participants were re-tested using the same measure to 
determine post- intervention values and the data learnt through the different tests can be analyzed for any 
statistical significance. 
 
2.5. Biochemical Analysis: 
2.5.1. Lactate in blood: 
The levels of lactate was measured by enzymatic determination from BioMeriex, France according to 
manufacturer instruction. The reference limit ( venous) is: 0.5 – 2.2 mmol/L. 
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2.5.2. Ceruloplasmin and Transferrin levels in serum: 
The levels of Ceruloplasmin and Transferrin were analyzed for the eighteen (18) autistic children as well as  the 
control group using the NEPHSTAR protein analysis system and the assay kits. (Goldsite Diagnostics In. China). 
In this test the immunephelo-meter is applied. 
The normal range of ceruloplasmin concentration of healthy adults is: 0.2- 0.6 g/L. 
The normal range of transferrin concentration of healthy adults is: 2- 3.6 g/L. 
 
2.6. State Evaluation: 
The study was based on the ATEC (Autistic Treatment Evaluation Checklist), which developed by ARI (the 
Autism Research Institute in San Diago, USA). The tool is provided for free and is available at 
( www.autism.com/atec/index.html). The tool is composed of four subscales: 
Scale I: Speech/Language Communication (14 items) –( Range 0 -28) 
 Scale II: Sociability (20 items)  –( Range 0 -40) 
Scale III: Sensory/ Cognition/Awareness (18 items) –( Range 0 -36)  
Scale IV: Health/ Physical behavior (25 items) –( Range 0 -75) 
Items on subscales 1-3 are scored from 0 (not a problem) to 2 (serious problem). The maximum true 
score is 179, the higher score indicates higher severity of autistic behaviors and poorer social developmental 
skills, lower scores indicates progress and improvement in autistic problems. The level of ATEC <30 places the 
child in the top 10 percentile. Such children have high chances of leading normal lives as independent 
individuals, while any child with a score of more than 104 would already be in the 90
th
 percentile and be 
considered very severely autistic. 
During the study, children were evaluated by the Autism Treatment Evaluation Checklist (ATEC), 
(Rimland, 1999). The ATEC is an assessment tool designed to be completed by either the parents or the 
researchers. The tool consists of four subscales: a) Speech/Language Communication; b) Sociability; c) 
Sensory/Cognition Awareness and d) Health/Physical/Behavior. The ATEC has been successfully used to 
measure treatment effects and progress over time in several studies in autism. (Geire.2013; Magiati 2011). 
The original purpose of ATEC is not to provide diagnostic tool. The tool included several subscale 
scores, in addition to the total score to be used for comparison.  
 
2.7. Statistical analysis:  
Lactate levels, in addition to the levels of ceruloplasmin and transferrin, as well as the (ATEC) scores for autism 
state were analyzed statically. Comparison was made between group, (a) autism group and their developmentally 
normal control group (b) autism group pre-intervention and post intervention. The measured values, expressed as 
the mean ± SD, were compared using unpaired students t-test, p<0.05 was considered as significant level. 
 
3. Results:  
3.1. lactate level in autism 
The reference interval of lactate in control children is 0.13 to 2- 2.2 mmol/L. Table 1. illustrates the levels of 
lactate in 18 children with autism and their non-autistic control. Statistical analysis (a) showed that lactate levels 
were significantly increased in whole autism group (mean± SD=2.6 ± 0.82 ) mmol/L as compared to whole non-
autistic control group (mean ± SD=1.3 ± 0.7 mmol/L , and (b) also, statistical analysis showed that lactate levels 
were significantly decreased in whole autism group post-intervention  (mean ± SD=1.88 ± 0.61) mmol/L as 
compared to the same group pre- electromagnetic intervention. 
 
3.2. Reduced Serum Ceruloplasmin levels in Autism  
Table 1. illustrates the levels of ceruloplasmin in 18 children with autism and their non-autistic control. 
Statistical analysis (a) showed that ceruloplasmin levels were significantly decreased in whole autism group 
(mean± SD=0.2200 ± 0.0418 ) mg/ml as compared to whole non-autistic control group(mean±  SD=0.3717 
±0.0498) mg/ml , and (b) also, statistical analysis showed that ceruloplasmin levels were significantly increased 
in whole autism group post-intervention  (mean±  SD=0.3494± 0.0417) mg/ml as compared to the same group 
pre- electromagnetic intervention (mean± SD=0.2200 ± 0.0418)mg/ml. The data was however, not significant 
when the mean levels of ceruloplasmin in autistic group post-intervention (0.349 ± 0.0417) mg/ml were 
compared with non-autistic control group mean levels (0.3717 ± 0.0498) mg/ml. 
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Table1. Oxidative stress indicators of autistic (Pre- and Post- intervention) and   control children 
Oxidative stress indicators Group No Mean ± SD                 P value 
 Pre-inter. 18 0.220±0.0418 p ≤o.o5 
Ceruloplasmin Post-inter. 18 0.349±0.0417  
 Control 18 0.371±0.0498  
 Pre-inter. 18 1.993±0.13 p ≤o.o5 
Transferrin Post-inter. 18 3.107±0.25  
 Control 18 3.072± 0.23  
 Pre-inter. 18 2.60 ±0.82 p≤ o.o5 
Lactate Post-inter. 18 1.88 ±0.61  
 Control 18 1.30±0.72  
 
3.3. Reduced Serum Transferrin levels in Autism 
The levels of transferrin in serum samples of( 18) children with autism, and their  non-autistic control group are 
shown in table 1. Statistical analysis (a) showed that transferrin levels were significantly decreased in whole 
autism group (mean ± SD=1.9933± 0.1303) mg/ml as compared to whole non-autistic control group(mean ± 
SD=3.0722± 0.2396)  mg/ml , and (b) also, statistical analysis showed that transferrin levels were significantly 
increased in whole autism group post-intervention  (mean ± SD=3.1072± 0.2519)  mg/ml as compared to the 
same group pre- electromagnetic intervention (mean± SD=1.9933± 0.1303)mg/ml. The data was however, not 
significant when the mean levels of transferrin  in autistic group post-intervention (3.1072±0.2519) mg/ml  were  
compared with non-autistic control group mean levels (3.0722± 0.2396) mg/ml. 
 
3.4. Assessment of the autism state by The Autism Treatment Evaluation Chicklist (ATEC) 
Mean ATEC score significantly decreased following initiation of treatment, indicating a decrease in severity of 
autism symptoms (table 2). Of the 20 respondents, 90% reported a decrease in total ATEC score. The remaining 
two respondents did not respond to EM treatment, registering reduction in total ATEC scores of less than 10 
points. It is not clear if they would improve if they had continued the treatment. Mean total ATEC values 
decreased by an average of 69.28% from 98.00 prior to treatment to 30.30 following treatment initiation (Figure 
1, P<0.05). 
Table 2. Autistic Disorder Characteristics (Pre- and post- Intervention) 
ATEC Domain 
    Scores 
No                         Mean ±SD 
Pre-Inter.                          Post-Inter. 
Percent of 
decrease 
Total  ATEC        20 98.00±16.46                     30.30 ±7.74                                                  69.08
Speech 20 22.00± 3.27                      14.30±2.71                               36.40 
Social 20 20.35± 2.15                        5.25±1.37                                    73.75 
Sensory 20 23.o5±3.33                         5.15±1.30                                    77.65 
Health 20 31.95 ±3.67                        6.30±1.38                                   80.28 
There were significant decreases observed following treatment initiation in all four of the ATEC 
categories (Figure 1). Mean speech/ language/communication ATEC scores decreased from 22.00 prior to 
treatment to 14.00 following treatment initiation (average decrease of -36.4%; P<0.05), with 56% of respondents 
reporting improvements. Sociability ATEC scores decreased by an average of 73.75% following treatment 
initiation, with improvements reported among 75% of respondents (P<.05). Sensory/Cognitive Awareness ATEC 
scores were decreased by an average of 77.65%, following treatment initiation with 72% of respondents 
reporting improvements (P<.05). In the health/physical/behavior domain, ATEC scores decreased by an average 
of 80.28%, from 31.95 prior to treatment to 6.30 following treatment initiation; 92% percent of respondents 
reported improvements in this domain (P<.05). 
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Figure 1: Decrease in Autism Severity Post Intervention. Mean  ATEC Scores significantly decreased across all 
domains (p< 0.05 for all domain n=20). Mean value with standard deviation shown 
 
 
4. Discussion 
Several recent studies described the treatment of some neurological disorders with an externally applied of 
electromagnetic field (Jacobson, et. al.,1994; Sandyk, R., 1992). 
For the treatment process, the device offers a flood of electrons, penetrating through permeable membranes 
throughout the tissues and neutralize these charges and correct the cells polarization. We correlate statically the 
electrical stimulation effects with the oxidative stress biomarkers as well as the improvement of autistic 
symptoms.    
Autism is a severe neurodevelopment disorder. According to the U.S.CDC ( July 2016), the prevalence 
of the autism spectrum disorder is about 1 in 68 children. Exclusive studies have demonstrated that oxidative 
stress plays a vital role in the pathology of several neurological diseases.  Oxidative stress results in an excess of 
free radicals which leading to organ dysfunction. (Halliwell B. 2012) suggested that oxidative stress can damage 
neurons and brain cells via product of lipid peroxidation. Also, (Chauhan et. al., 2004), reported that 
phospholipid composition of erythrocyte membrane is altered in autism. The mechanism of oxidative stress in 
autism is due to increased production of pro-oxidants, as well as the deficiencies of antioxidants enzymes and 
antioxidant proteins or both. 
 Mitochondria are the main intracellular source of free radicals. The mechanism by which a 
mitochondrial dysfunction might lead to autistic behavior is not known, but the direct involvement of an 
oxidative defect in the disturbance of early brain development is a plausible hypothesis (Lombard 1998). 
Recently, evidence has accrued that autistic children have concomitant diseases such as mitochondrial disease 
and abnormality of energy generation (Siddiqui F.M. et.al., 2016). Many recent studies finding support the 
hypothesis that there is an association of ASD with impaired mitochondrial function. There are several main 
outcome measures that revealed the mitochondrial dysfunction in autism such as oxidative phosphorylation 
capacity, mtDNA copy number and deletions, mitochondrial rate of hydrogen peroxide production, and plasma 
lactate and pyruvate. If the mitochondria is not working, glucose will turn into pyruvate, which will turn into 
lactate, which will turn into alanine. A lactate level is a simple, non-evasive, low- cost means for the initial 
diagnostic approach of mitochondrial problems ( Zeviani 1996). Elevated of lactate level blood samples from 
autistic children ranged from  17% to  76% ( Olivera 2005). Mostafa et. al., (2005 ) studied the mitochondrial 
dysfunction in autistic children and they found 77% of the children had high lactate levels than normal group. 
Also, Weissman et.al.,( 2008) found that lactate level were high in 76% of the autistic children. 
Our results suggest that the levels of lactate, were significantly increased in children with autism as 
compared to their non-autistic control, (13) out of (18) autistic children ,about 73,3% had higher lactate levels 
regarding the laboratory markers. This result is concomitant with that of ( Rossignol,D.A. and R.E.Frye 2012) 
who found that mean lactate content in 114 children with ASD was ( 1.73mmol/L), while in control group was 
(0.9mmol/L). On the other hand we found that children with severe autism had higher lactate compared to less 
severity. In fact, we found one case had high level of lactate (3.0 mmol/L) and this result remain without 
changing even after the intervention treatment, although his behavioral symptoms were improved more than 80%. 
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In general, we found that autism symptoms were improved in all cases that had decreasing levels in lactate 
contents. The different values of plasma lactate may be explained by the differences in chosen cut-off value 
above which the patient was considered to have lactatemia, number and age of studied autistic children.    
Our results suggest that the levels of ceruloplasmin and transferring, which are the major antioxidant 
proteins in the blood, are significantly reduced in children with autism as compared to their non-autistic control. 
This result is concomitant with that of ( Chauhan, et al., 2004), who reported lower levels of ceruloplasmin and 
transferrin  (68% and 84% respectively) in children with autism as compared to their developmentally normal 
siblings. Also ( Essa, et al., 2012), their study showed marked reduction in the levels of ceruloplasmin and 
transferring in Omani autistic children.  
Ceruloplasmin protects polyunsaturated fatty acids in the red blood cell membranes from active oxygen 
radicals (Arnaud et al.,1988). It acts as a ferroxidase and superoxide dismutase. 
Transferrin acts as an antioxidant by reducing the concentration of free ferrous ion that catalyzes the 
conversion of hydrogen peroxide to highly toxic hydroxyl radical by Fenton reaction. It has been reported that 
the lower levels of ceruloplasmin and transferrin are directly manifesting the state of autism in children with loss 
of acquired language skills(Chauhan,2004).  
Despite the extensive research in the use of antioxidants, there is not a clear-cut consensus that these 
antioxidants are totally successful in reducing free radicals. Other than antioxidants, there are different methods 
used to reduce free radicals such as the electro stimulation of specific acupuncture points (Shealy, et al., 2002; 
Russell 2006; Wang,et.al., 2013). By using types of transcutaneous electrical nerve stimulators they found that in 
individuals with positive urinary evidence of free radicals, there are a significant reduction in total free radical 
activity.  
In the current study, after the EM stimulation we found that lactae levels were decreased while 
ceruloplasmin and transferrin levels were increased in autistic group as compared to the same group pre-
intervention. Furthermore, the results suggest that there was a significant inverse correlation between protein 
antioxidant and autism severity measured using ATEC scoring. There were significant decreases observed 
following EM stimulation in all four of the ATEC categories. These finding confirmed that there could be 
significant health benefits from EM stimulation. However, the lowest improvement level of the ATEC categories 
was with speech subscale. Previous studies showed a positive correlation between reduced levels of these 
antioxidant proteins and loss of previously acquired language skills in children with autism. However, the 
underlying mechanism is still unclear and further extensive studies are warranted. 
The results confirmed that the EM stimulation making it easier for the antioxidants to connect with the 
free radicals, and thus prevent depolarization of cells. 
We applied this principle of treatment on several chronic diseases such as mental illness, diabetes, heart 
diseases, glands and food allergies, and we obtained prospective and encourage results with no known side 
effects. 
In conclusion, the strong correlation of the oxidative stress biomarkers and the ATEC scores, strongly 
suggested that oxidative stress biomarkers are associated with autism severity. 
The present study is a novel prospective study conducted to evaluate the autistic symptoms 
improvement after using a DC pulsating treatment. The highly decrease in ATEC scores and the parents reports, 
strongly emphasize the DC pulsating effects in healing and decreasing of autism severity with more than 80% of 
the participants. 
Finally, further practical studies with sophisticated instruments were needed to strictly correlate the 
treatment processes with a fixed mathematical equation responding to the biomagnetic field for every disease. 
In considering the potential limitation of the present study, the number of study participants was of 
moderate size. Despite this potential limitation, the consistency and specificity of the results observed were 
strengths of the present study. 
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